1. Home
  2. Directory
  3. Oregon
  4. Keizer
  5. Physical Medicine Rehabilitation
  6. NPI Profile
  7. Prescriptions 1114373602

DR. XIAOYUE LI M.D.
Prescription History 1114373602
Physical Medicine & Rehabilitation in Keizer, OR

NPI Status: Active since May 13, 2016

Contact Information

3624 RIVER RD N
KEIZER, OR
ZIP 97303
Phone: (503) 561-5976

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. XIAOYUE LI M.D., an active Physical Medicine & Rehabilitation specialist practicing in Keizer, OR. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 79 documented patient claims. Among these therapy options, the most frequently utilized medication is Tizanidine Hcl, which accounts for 40 claims alone.

Medication Index

B
G
L
T
No matching medications currently found on file.

Baclofen

Generic Formulation: BaclofenSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 353
OR State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills41.2
Peer Average Days Supply1,123
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 61.3% less volume than the regional standard for practitioners inside OR. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $805.78 across this reporting matrix range.

Provider Avg Cost Per Claim

$67.15

State Avg Cost Per Claim

$30.74

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A GAMMA-AMINOBUTYRIC ACID derivative that is a specific agonist of GABA-B RECEPTORS. It is used in the treatment of MUSCLE SPASTICITY, especially that due to SPINAL CORD INJURIES. Its therapeutic effects result from actions at spinal and supraspinal sites, generally the reduction of excitatory transmission.

Therapeutic Applications

Baclofen is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury/disease). It works by helping to relax the muscles.

Gabapentin

Generic Formulation: GabapentinSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 16
30-Day Fills 28.0
Days Supply 840
OR State Average Benchmarks
Peer Average Claims77.0
Peer Average 30-Day Fills132.0
Peer Average Days Supply3,873
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 79.2% less volume than the regional standard for practitioners inside OR. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $280.40 across this reporting matrix range.

Provider Avg Cost Per Claim

$17.53

State Avg Cost Per Claim

$26.29

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

Therapeutic Applications

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Lidocaine

Generic Formulation: LidocaineSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 11
30-Day Fills 13.0
Days Supply 375
OR State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills21.1
Peer Average Days Supply515
Conservative Utilization

This provider writes prescriptions for this formulation 42.1% less frequently than the standard regional baseline metric for practitioners inside OR. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $562.85 across this reporting matrix range.

Provider Avg Cost Per Claim

$51.17

State Avg Cost Per Claim

$100.45

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.

Therapeutic Applications

This product is used to help reduce itching and pain from certain skin conditions (such as scrapes, minor skin irritations, insect bites). It may also be used to help relieve nerve pain after shingles (infection with herpes zoster virus). Lidocaine belongs to a class of drugs known as local anesthetics. It works by causing a temporary loss of feeling in the area where you apply the patch.

Tizanidine Hcl

Generic Formulation: Tizanidine HclSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 40
30-Day Fills 63.0
Days Supply 1,890
OR State Average Benchmarks
Peer Average Claims34.0
Peer Average 30-Day Fills42.1
Peer Average Days Supply1,027
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across OR. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $849.73 across this reporting matrix range.

Provider Avg Cost Per Claim

$21.24

State Avg Cost Per Claim

$15.12

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury). It works by helping to relax the muscles.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. XIAOYUE LI M.D. provides transparency into local medical care patterns within Keizer, OR.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Physical Medicine & Rehabilitation** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.